mRNA |
CAL-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.4 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |